- Home
- AKR vs CLDX Comparison
AKR vs CLDX Comparison
Compare AKR & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AKR | CLDX |
|---|---|---|
| Founded | 1993 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.4B |
| IPO Year | 1996 | 1995 |
Fundamental Metrics
Financial Performance| Metric | AKR | CLDX |
|---|---|---|
| Price | $21.66 | $32.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $22.25 | ★ $46.60 |
| AVG Volume (30 Days) | ★ 1.6M | 866.3K |
| Earning Date | 04-28-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.69% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | ★ $410,757,000.00 | $12,743,000.00 |
| Revenue This Year | $3.21 | $111.39 |
| Revenue Next Year | $12.17 | $235.85 |
| P/E Ratio | $96.59 | ★ N/A |
| Revenue Growth | 14.20 | ★ 87.78 |
| 52 Week Low | $18.04 | $19.52 |
| 52 Week High | $22.90 | $35.83 |
Technical Indicators
Market Signals| Indicator | AKR | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 49.07 | 60.32 |
| Support Level | $19.81 | $28.51 |
| Resistance Level | $22.32 | $35.10 |
| Average True Range (ATR) | 0.45 | 1.17 |
| MACD | -0.11 | 0.46 |
| Stochastic Oscillator | 32.22 | 82.47 |
Price Performance
Historical ComparisonAbout AKR Acadia Realty Trust
Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company operates through three segments: REIT Portfolio segment consists of high-quality retail properties located in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon; Investment Management segment holds the retail real estate in which the company co-invests with high-quality institutional investors; and Structured Financing segment consists of earnings and expenses related to notes and mortgages receivable Fees earned by the company as the general partner or managing member through Investment Management.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.